In the repore in which Astwood described the use of thiouracil for the treatment of human thyrotoxicosis he was fortunately able to indicate the most serious hazard which the administration of this drug entails, that of agranulocytosis. A great volume of work has confirmed both the effect of thiouracil on thyroid hyperfunction and its occasionally toxic effect on the bone marrow. Since this idiosyncratic reaction has constituted the main obstacle to the universal use of the drug, search has been made for agents which would prevent the occurrence of granulocytopenia, or rapidly abolish it when it occurred.
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Prolonged administration of thiourea to rats was shown by Goldsmith et al.7 to produce a neutropenia which could be prevented by the simultaneous use of solubilized liver; the active agent in this liver fraction was thought to be folic acid. 7 Vilter, Schiro, and Spies1' observed that intravenous injections of pyridoxine were followed by an increase in elements of the granulocytic series in the blood. Pyridoxine was reported by Cantor appears to be discontinuance of therapy at the earliest sign of this complication and prompt institution of vigorous treatment" (i.e., penicillin).
The clinical note of Newman and Jones' (which appeared while this manuscript was being prepared) clearly demonstrates that even as much as 30 mg. of crystalline folic acid per day is incapable of preventing the agranulocytosis which may be caused by thiouracil.
Careful study of case reports on patients with agranulocytosis reveals a wide variation in the course of the disease after withdrawal of the inciting drug. A substance possessing curative powers for this condition should, ideally, be able to exert them in the continuing presence of the drug. Since such an experiment is too hazardous to perform on human subjects, it is felt that its results on another primate are of interest.
Procedure and results Thiouracil* was administered in relatively large doses for several months to a group of adult rhesus monkeys.' The problem of determining the "normal" blood count in monkeys has been fully discussed by Crafts,0 who always found more than 5000 neutrophiles per cu.mm. Using his criteria, two animals weighing 4750 gm. and 4530 gm., respectively, were discovered to have developed a really significant granulocytopenia. When this study was begun, the animals had been receiving an average of 0.15 gm. of thiouracil per kg. of body weight per day for more than 110 days.
During the following eight weeks, white blood and differential counts were performed weekly on blood drawn directly from the popliteal vein. At the end of this period, without altering the thiouracil regimen, each animal was given an intravenous injection of 100 mg. of pyridoxine on each of five successive days and a sixth injection on the seventh day. White blood and differential counts were made immediately prior to each injection and two and four days after the last injection. From the results presented in the table it is evident that the blood picture was not significantly altered. Neither pyridoxine nor folic acid when given in conjunction with thiouracil corrected the granulocytopenia produced in two monkeys by prolonged thiouracil administration.
